Mr. Dahl’s vision, collaboration, technical expertise and leadership are instrumental for efficient operations, positive patient experiences and research innovation at the pioneering Roswell Park Comprehensive Cancer Center. His work to implement numerous patient access, scheduling, revenue cycle and full-suite clinical applications supports high-quality patient care and translational oncology research. Having first joined Roswell Park in 2014, his recent focuses include reimagining clinic standardization and helping to pilot enterprise AI-based speech recognition. Mr. Dahl has led the team that delivered integrations for an algorithm-based scheduling solution for infusion therapy clinics, and is currently collaborating with physician-researchers to deploy innovative medical technologies enabling non-excision dermatologic biopsies.
